Trial status
Accrural began on August 29, 2018. The current protocol is version 2.3, October 22, 2021.The estimated completion date for the primary endpoint is June 2026.Accrural will be carried out for 6 years, for a total duration of 11 years for the study (5 years after randomization of the last patient).